Clareo Health | Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Center For Excellence In Eye Care
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
· Male or female \> 18 years of age scheduled to undergo cataract surgery
* Must be in good general health. Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (ie diabetics with normal retinal exams)
* Expected visual outcome of 20/25 or better.
* Ability to provide informed consent and likely to complete all study visits
You may not be if
· Known contraindication to any study medication or any of their components
* Uncontrolled systemic disease
* Required use of ocular medications other than the study medications during the study
* Abnormal pre-operative OCTs
* Diabetic patients with a history of macular edema or diabetic retinopathy
* AMD, epi-retinal membranes, retinal vein occlusion, or any pre-existing macular disease
